DIN 02559625 — BLENREP 100 MG
BLENREP is a powder for solution of Belantamab mafodotin marketed by GLAXOSMITHKLINE INC. The full Belantamab mafodotin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02559625
- Brand name
- BLENREP
- Active ingredient
- Belantamab mafodotin
- Strength
- 100 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- BCMA-targeted antibody-drug conjugate (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Belantamab mafodotin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02559617 | BLENREP | 70 MG | POWDER FOR SOLUTION | GLAXOSMITHKLINE INC | MARKETED |